https://scholars.lib.ntu.edu.tw/handle/123456789/527628
標題: | Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension | 作者: | Mulatero P. Monticone S. Deinum J. Amar L. Prejbisz A. Zennaro M.-C. Beuschlein F. Rossi G.P. Nishikawa T. Morganti A. Seccia T.M. YEN-HUNG LIN Fallo F. Widimsky J. |
公開日期: | 2020 | 出版社: | NLM (Medline) | 卷: | 38 | 期: | 10 | 起(迄)頁: | 1919-1928 | 來源出版物: | Journal of hypertension | 摘要: | : Autonomous aldosterone overproduction represents the underlying condition of 5-10% of patients with arterial hypertension and carries a significant burden of mortality and morbidity. The diagnostic algorithm for primary aldosteronism is sequentially based on hormonal tests (screening and confirmation tests), followed by lateralization studies (adrenal CT scanning and adrenal venous sampling) to distinguish between unilateral and bilateral disease. Despite the recommendations of the Endocrine Society guideline, primary aldosteronism is largely underdiagnosed and undertreated with high between-centre heterogeneity. Experts from the European Society of Hypertension have critically reviewed the available literature and prepared a consensus document constituting two articles to summarize current knowledge on the epidemiology, diagnosis, treatment, and complications of primary aldosteronism. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85090375920&doi=10.1097%2fHJH.0000000000002510&partnerID=40&md5=af857acd445a39cfa09d2ace2cda5abf https://scholars.lib.ntu.edu.tw/handle/123456789/527628 |
ISSN: | 1473-5598 | DOI: | 10.1097/HJH.0000000000002510 | SDG/關鍵字: | aldosterone; blood; consensus; genetics; human; hyperaldosteronism; hypertension; prevalence; Aldosterone; Consensus; Humans; Hyperaldosteronism; Hypertension; Prevalence |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。